The treatment of mitral valve disease remains dynamic. Within the past few years, new concepts in leaflet repair techniques have emerged, and transcatheter alternatives for mitral valve repair and replacement have evolved.
Since the introduction of the “French Correction” by Carpentier, that remarks the importance of leaflets’ resection, innovation in valve repair has primarily focused on techniques for leaflet remodeling, neochordae implantation, and the minimization of leaflet resection.
Moreover, several different approaches have been proposed in surgery to minimize its invasiveness. To date, no particular technique has definitively demonstrated superiority relative to another, and benefits of minimally invasive and robotic mitral valve surgery is still a point of debate. In this scenario, recently, there has been rapid adoption and implementation of percutaneous treatments for mitral valve disease: the transcatheter edge-to-edge repair, transapical neochordal implantation or percutaneous annuloplasty (directly, or indirectly through coronary sinus remodeling). Finally, transcatheter alternatives for mitral valve replacement are emerging.
This Research Topic will accept manuscripts within this area of research, with the aim of providing the reader with an overview of the latest evidence or new findings regarding the different approaches in the case of mitral valve repair (resectional vs non-resectional techniques, sternotomy vs minimally invasive/robotic surgery) or transcatheter therapies. Analysis of previously published data, new opinions and perspectives, and methods and protocols (when relevant) are encouraged for submission.
The treatment of mitral valve disease remains dynamic. Within the past few years, new concepts in leaflet repair techniques have emerged, and transcatheter alternatives for mitral valve repair and replacement have evolved.
Since the introduction of the “French Correction” by Carpentier, that remarks the importance of leaflets’ resection, innovation in valve repair has primarily focused on techniques for leaflet remodeling, neochordae implantation, and the minimization of leaflet resection.
Moreover, several different approaches have been proposed in surgery to minimize its invasiveness. To date, no particular technique has definitively demonstrated superiority relative to another, and benefits of minimally invasive and robotic mitral valve surgery is still a point of debate. In this scenario, recently, there has been rapid adoption and implementation of percutaneous treatments for mitral valve disease: the transcatheter edge-to-edge repair, transapical neochordal implantation or percutaneous annuloplasty (directly, or indirectly through coronary sinus remodeling). Finally, transcatheter alternatives for mitral valve replacement are emerging.
This Research Topic will accept manuscripts within this area of research, with the aim of providing the reader with an overview of the latest evidence or new findings regarding the different approaches in the case of mitral valve repair (resectional vs non-resectional techniques, sternotomy vs minimally invasive/robotic surgery) or transcatheter therapies. Analysis of previously published data, new opinions and perspectives, and methods and protocols (when relevant) are encouraged for submission.